Neuropathology of older persons without cognitive impairment from two community-based studies

Neurology

Volumn 66, Issue 12, 2006, Pages 1837-1844

  Bennett, D A ^a,b   Schneider, J A ^a,b   Arvanitakis, Z ^a,b   Kelly, J F ^a,b   Aggarwal, N T ^a,b   Shah, R C ^a,b   Wilson, R S ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACADEMIC ACHIEVEMENT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN INFARCTION; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; FEMALE; GERIATRIC PATIENT; HUMAN; LEWY BODY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPATHOLOGY; NEUROPSYCHOLOGICAL TEST; PERCEPTION; PRIORITY JOURNAL; SAMPLE SIZE; SEMANTICS; SEX RATIO; WORKING MEMORY;

AGE FACTORS; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; BIAS (EPIDEMIOLOGY); COGNITION DISORDERS; COMMUNITY HEALTH SERVICES; COMORBIDITY; DEMENTIA; FEMALE; HUMANS; INCIDENCE; MALE; NEUROPSYCHOLOGICAL TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS; UNITED STATES;

EID: 33745876233     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000219668.47116.e6     Document Type: Article

References (58)

1. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci 1968;7:331-356.
2. Katzman R, Terry R, DeTeresa R, et al. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 1988;23:138-144.
3. Crystal HA, Dickson DW, Sliwinski MJ, et al. Pathological markers associated with normal aging and dementia in the elderly. Ann Neurol 1993;34:566-573.
4. Morris JC, Storandt M, McKeel DW Jr., et al. Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 1996;46:707-719.
5. Geddes JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S99-S105.
6. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 1998;57:1168-1174.
7. Haroutunian V, Purohit DP, Perl DP, et al. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 1999;56:713-718.
8. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999;58:376-388.
9. Lim A, Tsuang D, Kukull W, et al. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J Am Geriatr Soc 1999;47:564-569.
10. Green MS, Kaye JA, Ball MJ. The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old. Neurology 2000;54:105-113.
11. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet 2001;357:169-175.
12. Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003;62:1087-1095.
13. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-842.
14. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology 2000;55:370-376.
15. Galvin JE, Powlishta KK, Wilkins K, et al. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch Neurol 2005;62:758-765.
16. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 2002;51:567-577.
17. Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 2003;60:729-736.
18. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon CF, Bienias JL, Wilson RS. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005;25:163-175.
19. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
20. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Subtypes of acute ischemic stroke definitions for multi-center clinical trials. Stroke 1993;24:35-41.
22. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies - Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
23. Langston JW, Widner H, Goetz CGT, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
24. Robins LN, Helzer JE, Ratcliff KS, Seyfried W. Validity of the Diagnostic Interview Schedule, II: DSM-III diagnoses. Psychol Med 1982;12:855-870.
25. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
26. Welsh KA, Butters NC, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part V: a normative study of the neuropsychological battery. Neurology 1994;44:609-614.
27. Wechsler D. Wechsler Memory Scale-Revised manual. San Antonio, TX: Psychological Corp., 1987.
28. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea and Febiger, 1983.
29. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological Services, 1982.
30. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment. 2nd ed. New York: Oxford University Press, 1992.
31. Raven JC, Court JH, Raven J. Manual for Raven's progressive matrices and vocabulary scales. Oxford, UK: Oxford University Press, 1992.
32. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
33. Wilson RS, Barnes LL, Kreuger KR, Hoganson G, Bienias JL, Bennett DA. Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsych Soc 2005;11:400-407.
34. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer's disease pathology. Neurology 2004;62:1148-1152.
35. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
36. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
37. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18(4 Suppl):S1-2.
38. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
39. SAS Institute Inc. SAS Online Doc R 9.1.3. Cary, NC: SAS Institute Inc., 2004.
40. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
41. Dickson DW, Crystal HA, Mattiace LA, et al. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging 1992;13:179-189.
42. Geerlings MI, Schmand B, Braam AW, Jonker C, Bouter LM, van Tilburg W. Depressive symptoms and risk of Alzheimer's disease in more highly educated older people. J Am Geriatr Soc 2000;48:1092-1097.
43. Kudo T, Imaizumi K, Tanimukai H, et al. Are cerebrovascular factors involved in Alzheimer's disease? Neurobiol Aging 2000;21:215-224.
44. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.
45. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998;51(Suppl 1):S2-S17.
46. Mortimer JA. Brain reserve and the clinical expression of Alzheimer's disease. Geriatrics 1997;52(suppl 2):550-553.
47. Friedland RP. Epidemiology, education, and the ecology of Alzheimer's disease. Neurology 1993;43:246-249.
48. Schoenemann PT, Budinger TF, Sarich VM, Wang WS. Brain size does not predict general cognitive ability within families. Proc Natl Acad Sci USA 2000;97:4932-4937.
49. Mortimer JA, Snowdon DA, Markesbery WR. Head circumference, education and risk of dementia: findings from the Nun Study. J Clin Exp Neuropsychol 2003;25:671-679.
50. Borenstein Graves A, Mortimer JA, Bowen JD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 2001;57:1453-1460.
51. Schofield PW, Logroscino G, Andrews HF, Albert S, Stern Y. An association between head circumference and Alzheimer's disease in a population-based study of aging and dementia. Neurology 1997;49:30-37.
52. Buckner RL. Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron 2004;44:195-208.
53. Stern Y, Habeck C, Moeller J, Scarmeas N, Anderson KE, Hilton HJ. Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex 2005;15:394-402.
54. Grady CL, Furey ML, Pietrini P, Horwitz B, Rapoport SI. Altered brain functional connectivity and impaired short-term memory in Alzheimer's disease. Brain 2001;124:739-756.
55. Sperling RA, Bates JF, Chua EF, et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:44-50.
56. Mortimer JA, Borenstein AR, Gosche KM, Snowdon DA. Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression. J Geriatr Psychiatry Neurol 2005;18:218-223.
57. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Education modifies the association of amyloid but not tangles with cognitive function. Neurology 2005;65:953-955.
58. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Berry-Kravis E, Arnold SE. Amyloid mediates the association of apolipoprotein E ε4 to level of cognitive function in older persons. J Neurol Neurosurg Psychiatry 2005;76:1194-1199.